Form 4: Molina Healthcare Director Richard Schapiro Acquires Shares Under Equity Incentive Plan

Sentiment:

SEC Form 4 Filing


Director Richard Schapiro acquired 161 shares of Molina Healthcare common stock on October 1, 2024, as part of the company's 2019 Equity Incentive Plan.

Summary

  • Richard M. Schapiro, a director of Molina Healthcare, Inc., acquired 161 shares of common stock on October 1, 2024.
  • The acquisition was made under the company's 2019 Equity Incentive Plan.
  • The shares were granted as part of the annual equity award to directors, with one quarter of the $220,000 annual award granted each quarter.
  • The grant was based on the closing price of Molina Healthcare's common stock on October 1, 2024, which was $341.91 per share.
  • Following the transaction, Schapiro directly owns 11,692 shares of Molina Healthcare common stock.
  • Jeff D. Barlow, acting as power of attorney for Richard M. Schapiro, signed the report.

Sentiment

Score: 7

Explanation: Routine transaction reflecting standard director compensation practices. Positive as it aligns director interests with shareholders.

Positives

  • The acquisition of shares by a director signals confidence in the company's future.
  • The equity incentive plan aligns director interests with those of shareholders.

Industry Context

Director share acquisitions are common in publicly traded companies as part of compensation packages and to align the interests of directors with shareholders. This is a routine transaction.

Comparison to Industry Standards

  • Director compensation packages, including equity grants, are common across the healthcare industry.
  • Companies like UnitedHealth Group, Anthem, and Cigna also utilize equity-based compensation for their directors.
  • The specific value and structure of these grants vary based on company size, performance, and compensation philosophy.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders by aligning director interests with shareholder value.

Key Dates

DateDescription
July 29, 2015Date of Limited Power of Attorney for Section 16(a) Filings
October 01, 2024Date of stock acquisition
October 02, 2024Date of signing the report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.